These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2455020)

  • 21. Cerebro-hepato-renal (Zellweger) syndrome, adrenoleukodystrophy, and Refsum's disease: plasma changes and skin fibroblast phytanic acid oxidase.
    Poulos A; Sharp P; Fellenberg AJ; Danks DM
    Hum Genet; 1985; 70(2):172-7. PubMed ID: 2408988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phytanic acid and very long chain fatty acids in genetic peroxisomal disorders.
    Molzer B; Kainz-Korschinsky M; Sundt-Heller R; Bernheimer H
    J Clin Chem Clin Biochem; 1989 May; 27(5):309-14. PubMed ID: 2474624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peroxisomal functions in classical Refsum's disease: comparison with the infantile form of Refsum's disease.
    Wanders RJ; Heymans HS; Schutgens RB; Poll-Thé BT; Saudubray JM; Tager JM; Schrakamp G; van den Bosch H
    J Neurol Sci; 1988 Apr; 84(2-3):147-55. PubMed ID: 2454298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phytanic acid alpha-oxidation and complementation analysis of classical Refsum and peroxisomal disorders.
    Poll-The BT; Skjeldal OH; Stokke O; Poulos A; Demaugre F; Saudubray JM
    Hum Genet; 1989 Jan; 81(2):175-81. PubMed ID: 2463966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autopsy findings in two siblings with infantile Refsum disease.
    Chow CW; Poulos A; Fellenberg AJ; Christodoulou J; Danks DM
    Acta Neuropathol; 1992; 83(2):190-5. PubMed ID: 1373019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peroxisomal disorders I: biochemistry and genetics of peroxisome biogenesis disorders.
    Wanders RJ; Waterham HR
    Clin Genet; 2005 Feb; 67(2):107-33. PubMed ID: 15679822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neuropathology of peroxisomal disorders; Zellweger syndrome and neonatal adrenoleukodystrophy].
    Takashima S; Houdou S; Kamei J; Hasegawa M; Mito T; Suzuki Y; Maeda K
    No To Hattatsu; 1992 Mar; 24(2):186-93. PubMed ID: 1567656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver pathology and immunocytochemistry in congenital peroxisomal diseases: a review.
    Roels F; Espeel M; De Craemer D
    J Inherit Metab Dis; 1991; 14(6):853-75. PubMed ID: 1779645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological induction of peroxisomes in peroxisome biogenesis disorders.
    Wei H; Kemp S; McGuinness MC; Moser AB; Smith KD
    Ann Neurol; 2000 Mar; 47(3):286-96. PubMed ID: 10716247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenotype of patients with peroxisomal disorders subdivided into sixteen complementation groups.
    Moser AB; Rasmussen M; Naidu S; Watkins PA; McGuinness M; Hajra AK; Chen G; Raymond G; Liu A; Gordon D
    J Pediatr; 1995 Jul; 127(1):13-22. PubMed ID: 7541833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peroxisomal disorders.
    Aubourg P; Wanders R
    Handb Clin Neurol; 2013; 113():1593-609. PubMed ID: 23622381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Partial deficiency of dihydroxyacetone phosphate acyltransferase activity in both classical and infantile Refsum's diseases.
    Van Crugten JT; Paton B; Poulos A
    J Inherit Metab Dis; 1986; 9(2):163-8. PubMed ID: 2427794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Central nervous system malformations and white matter changes in pseudo-neonatal adrenoleukodystrophy.
    Kyllerman M; Blomstrand S; Månsson JE; Conradi NG; Hindmarsh T
    Neuropediatrics; 1990 Nov; 21(4):199-201. PubMed ID: 2290480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infantile Refsum's disease: a peroxisomal storage disorder?
    Manson JI; Pollard AC; Poulos A; Carter RF
    Clin Exp Neurol; 1985; 21():283-7. PubMed ID: 2436838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human liver pathology in peroxisomal diseases: a review including novel data.
    Roels F; Espeel M; Poggi F; Mandel H; van Maldergem L; Saudubray JM
    Biochimie; 1993; 75(3-4):281-92. PubMed ID: 7685191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pathology of peroxisomal disorders with pathogenetic considerations.
    Powers JM
    J Neuropathol Exp Neurol; 1995 Sep; 54(5):710-9. PubMed ID: 7666061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Very long-chain fatty acids in peroxisomal disease.
    Poulos A; Beckman K; Johnson DW; Paton BC; Robinson BS; Sharp P; Usher S; Singh H
    Adv Exp Med Biol; 1992; 318():331-40. PubMed ID: 1378993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical and molecular aspects of peroxisome-deficient disorders].
    Suzuki Y; Shimozawa N; Orii T
    Nihon Rinsho; 1993 Sep; 51(9):2353-8. PubMed ID: 7692118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peroxisomal disorders: genotype, phenotype, major neuropathologic lesions, and pathogenesis.
    Powers JM; Moser HW
    Brain Pathol; 1998 Jan; 8(1):101-20. PubMed ID: 9458170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Peroxysomes in infantile Refsum's disease].
    Roels F
    Presse Med; 1987 Dec; 16(42):2131-2. PubMed ID: 2448765
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.